Acupuncture with Chinese herbal cream versus acupuncture with calcipotriol for plaque psoriasis
Official title: Comparative Efficacy of Acupuncture Combined With Chinese Herbal Cream and Acupuncture Combined With Calcipotriol for Plaque Psoriasis.
Run by Mae Fah Luang University · NCT07410793 · Data updated 2026-11-12
This project will see if acupuncture plus a Chinese herbal cream works as well as acupuncture plus calcipotriol ointment for people with mild plaque psoriasis.
Quick facts
| Phase | Phase 2 |
|---|---|
| Study type | Interventional |
| Ages | 18 Years to 65 Years |
| Sex | All |
| Enrollment | 28 (estimated) |
| Sponsor | Mae Fah Luang University Academic / other |
| Locations | 1 site (Muang, Chiangrai) |
| Status | Recruiting |
| Started | February 9, 2026 |
| Main results expected | February 8, 2027 |
| Study ends | February 8, 2027 |
| Registry record updated | February 13, 2026 |
| Trial ID | NCT07410793 on ClinicalTrials.gov |
Is this trial a fit for you?
✓Likely a good fit
Adults with mild plaque psoriasis (≤10% BSA, PASI ≤10, DLQI ≤10) who have not used psoriasis treatments for at least four weeks and who can undergo acupuncture are ideal candidates.
✕Probably not a fit
Patients with extensive or non-plaque forms of psoriasis, recent biologic or immunosuppressive therapy, pregnancy, anticoagulant use, needle phobia, or uncontrolled systemic disease are unlikely to benefit or be eligible.
A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.
What this trial studies
This Phase 2 interventional study compares two combination treatments for plaque psoriasis: acupuncture with a topical Chinese herbal cream versus acupuncture with topical calcipotriol 0.005% ointment. Eligible adults have mild plaque psoriasis (≤10% body surface area, PASI ≤10, DLQI ≤10) and must be off other psoriasis treatments for at least four weeks. Participants are assigned to receive acupuncture together with one of the topical preparations and will have skin severity and quality-of-life measures recorded before and after the treatment period. The trial is conducted at Mae Fah Luang University in Chiangrai, Thailand, and excludes patients with non-plaque psoriasis types, major uncontrolled illnesses, recent biologic therapy, anticoagulant use, pregnancy, or needle phobia.
Why it matters
Potential benefit: If successful, this approach could offer an alternative topical option combined with acupuncture that improves skin symptoms and quality of life for patients with mild plaque psoriasis.
How similar studies have gone: Small trials and observational reports have shown mixed or limited benefits from acupuncture and topical herbal therapies for psoriasis, so this combined approach remains promising but not yet well proven.
Who can join: the full rules
Show full inclusion / exclusion criteria
Inclusion Criteria: * Plaque psoriasis on skin, scalp, or nails * Not receive any psoriasis treatment at least 4 weeks prior to the study * ≤10% body surface area (BSA), PASI≤10, DLQI≤10 Exclusion Criteria: * Pregnancy and lactation * Other type of psoriasis i.e. Psoriatic arthritis, Pustular psoriasis, Erythrodermic psoriasis * Uncontrollable diseases i.e. CVS, liver, kidney, cancer * Using anticoagulants i.e. Aspirin, Warfarin, Clopidogrel, Dabigatran, Riavaraxaban, Apixaban, Heparin * Treated with psoriasis biologic agents in the past 6 months * Needle phobia * Receiving immunosuppresive agents i.e. systemic corticosteroid, NSAIDs, chemotherapeutic agents * Participating in other clinical study
Where it's running
-
Mae Fah Luang University
Muang, Chiangrai, Thailand Recruiting
Study contacts
- Study coordinator: Dr.Sinee Tantasatityanon, TCMD, PhD
- Email: sinee.tan@mfu.ac.th
- Phone: +66818092078
Similar studies
Other studies for the same condition or treatment. Recruiting studies are listed first.
-
Topical PROXERA PSOMED 20 or 40 for psoriasis in adults
This study tests whether applying PROXERA PSOMED 20 or 40 to a psoriasis-affected area helps more than the untreated area on the same person.
How to take part
- Review the eligibility criteria above with your treating physician.
- Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
- Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.